Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment

High Times
By Thomas EdwardMay 26, 2023, 10:00 am216 pts
Tryp Therapeutics announced on Wednesday that it had “submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its planned Phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Marijuana rescheduling looms as Senate Republicans move on Trump DEA pick 79

Cannabis sales now allowed at all-ages events in Alberta 76

iAnthus Continues Florida Expansion With GrowHealthy Dispensary in Palm Harbor 75

Current Roadside Tests For Marijuana Impairment Are ‘Pseudoscientific,’ Law Professor Says 75

Twister Technologies post-harvest automation & AI solutions 74

More Seniors Turning to Cannabis, But What’s the Appeal? 73

Report: Global Hemp Fiber Market to Surpass $30B by 2033 71

California State Fair Exhibit Charges One Penny for Cannabis Seeds 71

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.